Colgate-Palmolive (NYSE: CL) recently received a number of ratings updates from brokerages and research firms:

  • 10/2/2017 – Colgate-Palmolive was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $82.00 price target on the stock. According to Zacks, “Colgate has outperformed the industry in the past month. We remain encouraged by the progress on its 2012 Restructuring Program and expect additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view. Moreover, the company has been infamous among investors with its meet or beat earnings track record. However, the company’s sales missed expectations for the fifth straight quarter in second-quarter due to continued softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Nevertheless, the company remains focused on four fundamentals to boost profits including, increased spending on advertisements; innovation across portfolio; higher spends on e-commerce business and aggressively maximizing productivity. Also, its disciplined capital strategy bodes well. Estimates have been stable lately.”
  • 9/28/2017 – Colgate-Palmolive had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $79.00 price target on the stock.
  • 9/26/2017 – Colgate-Palmolive was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Colgate has outperformed the industry in the past month. We remain encouraged by the progress on its 2012 Restructuring Program and expect additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view. Moreover, the company has been infamous among investors with its meet or beat earnings track record. However, the company’s sales missed expectations for the fifth straight quarter in second-quarter due to continued softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Nevertheless, the company remains focused on four fundamentals to boost profits including, increased spending on advertisements; innovation across portfolio; higher spends on e-commerce business and aggressively maximizing productivity. Also, its disciplined capital strategy bodes well. Estimates have been stable lately.”
  • 9/25/2017 – Colgate-Palmolive was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $84.00 price target on the stock, up previously from $75.00. They wrote, “Our new $84 PT is based on ~24.5x times our upwardly revised FY19 EPS estimate (~23xex a 7.5% strategic halo), representing a ~20% return with a ~2% dividend yield,” the firm said.”Furthermore, we see a 2:1 ratio of bull case upside relative to bear case downside.”
  • 9/25/2017 – Colgate-Palmolive was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $80.00 price target on the stock. According to Zacks, “Colgate has outperformed the industry in the past month. We remain encouraged by the progress on its 2012 Restructuring Program and expect additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view. Moreover, the company has been infamous among investors with its meet or beat earnings track record. However, the company’s sales missed expectations for the fifth straight quarter in second-quarter due to continued softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Nevertheless, the company remains focused on four fundamentals to boost profits including, increased spending on advertisements; innovation across portfolio; higher spends on e-commerce business and aggressively maximizing productivity. Also, its disciplined capital strategy bodes well. Estimates have been stable lately.”
  • 9/20/2017 – Colgate-Palmolive was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Colgate, which has underperformed the industry in the past three months, has a dismal sales surprise history. Evidently, the company has lagged sales estimates in 16 out of the trailing 17 quarters. Well, Colgate marked its fifth straight sales miss in the last reported quarter, mainly due to continued softness in North America and challenges in Asia-Pacific. Furthermore, low global unit volumes and adverse currency fluctuations were deterrents. Going forward, the company anticipates the backdrop to remain challenging due to uncertain global markets and slowing category growth worldwide. Consequently, the company lowered its organic sales growth and GAAP earnings guidance for 2017. Nevertheless, we commend Colgate’s progress on its 2012 Restructuring Program. Notably, management expects additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings forecast.”
  • 9/14/2017 – Colgate-Palmolive is now covered by analysts at Macquarie. They set a “neutral” rating and a $76.00 price target on the stock.
  • 8/24/2017 – Colgate-Palmolive had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $79.00 price target on the stock.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 72.44 on Wednesday. The stock has a 50 day moving average of $71.88 and a 200 day moving average of $73.18. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a market cap of $63.81 billion, a price-to-earnings ratio of 26.92 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the prior year, the company posted $0.70 EPS. Colgate-Palmolive’s quarterly revenue was down .5% compared to the same quarter last year. Analysts predict that Colgate-Palmolive Company will post $2.89 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.21%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

In related news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the sale, the insider now owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now directly owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Over the last quarter, insiders sold 217,969 shares of company stock worth $15,693,933. Corporate insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.